Soliris, the world’s most expensive drug

Approved in 2011 as the first and only treatment for the very rare, life-threatening blood disorder atypical haemolytic uremic syndrome (aHUS), Soliris has transformed the lives of sufferers, turning it from a potential killer into a chronic but manageable condition.
Soliris is the most expensive drug because the treatment costs over $500.000 per patient per year.


One of the reasons Eculizumab, also known as Soliris is so expensive is because the drug companies must recoup their research costs from a small number of patients.
England’s healthcare cost effectiveness watchdog agrees with pharma company Alexion that Soliris (ecluzimab) is very effective in treating patients with aHUS, which causes blood clots in small blood vessels in the body, leading to kidney failure and the need for dialysis or kidney transplants.

Share This Post

Leave a reply

%d bloggers like this: